Interneuron Licenses Treatment For Liver Disease

, Inc. has exercised its option and entered into an agreement to license IP 501, an orally-administered anti-fibrotic purified phospholipid compound in Phase 3 development for the treatment and prevention of liver diseases, including alcohol and Hepatitis C-induced cirrhosis.

The license agreement gives Interneuron rights to develop and commercialise the drug in several major markets, including the United States and Japan.

In addition, the Company announced the initiation of a government-funded Phase 3 clinical trial evaluating IP 501 in Hepatitis C. IP 501 is the subject of a recently completed Phase 3 clinical trial funded by the government to evaluate the compound in alcoholic cirrhosis.

The primary endpoint of the study is reduction in the progression of cirrhosis among drug-treated pre-cirrhotic patients compared with placebo patients, as measured by serial liver biopsies.

The Company expects to receive a preliminary analysis of the data in the first quarter of this year.

In addition to this trial, IP 501 is also being studied in another government-funded, multi-centre, Phase 3 clinical trial.

This recently initiated, multi-year trial is designed to evaluate the safety and effectiveness of IP 501 in treating patients with Hepatitis C-associated cirrhosis.

Under the terms of the license agreement, the Company has acquired rights to develop and commercialise IP 501 in the United States, Canada, Japan, Korea, and, under certain circumstances, Europe and other markets.

Interneuron is responsible for all remaining clinical and regulatory development, manufacturing, and marketing of the compound.

Interneuron Pharmaceuticals is a biopharmaceutical company engaged in the development and commercialisation of a diversified portfolio of product candidates, including multiple compounds in late- stage clinical development.

Order Dragon Pharma

NPP 150 - Cheap Price

Administration: Injection
Prime Ingredient: Nandrolone Phenylpropionate
Producer: Dragon Pharma Labs
Amount: 20 x 10 mL vial (150 mg/mL)
Price: 20 x $25.00

Masteron 200

Injectable Anabolic Steroid
Primary Chemical Name: Drostanolone Enanthate
Produced by: Dragon Pharmaceutical
Pack: 1 X 10 ml (200 mg/ml)

Primobolan 100 - Discount Price

Administration: Injection
Basal Chemical Name: Methenolone Enanthate
Manufacturer: Dragon Pharma
Unit: 30 x 10 mL vial (100 mg/mL)
Price: 30 x $55.00

Sustanon 350 - Cheap Price

Administration: Injection
Principal Component: Testosterone Blend
Produced by: Dragon Pharma Labs
Pack: 20 x 10 mL vial (350 mg/mL)
Price: 20 x $40.00

Propionat 100 - Cheap Price

Administration: Injection
Basal Constituent: Testosterone Propionate
Producer: Dragon Pharmaceutical
Unit: 20 x 10 mL vial (100 mg/mL)
Price: 20 x $25.00

Winstrol Tabs

Synthetic Anabolic Steroidal Agent
Basic Component: Stanozolol
Made by: Dragon Pharma
Amount: 1 X 100 tablets (50 mg/pastille)

Parabolan 100 - Cheap Price

Administration: Injection
Basic Ingredient: Trenbolone Hexahydrobenzylcarbonate
Produced by: Dragon Pharma LLC
Amount: 20 x 10 mL vial (100 mg/mL)
Price: 20 x $55.00

Cut Mix 150 - Discount Price

Administration: Injection
Main Constituent: Testosterone Propionate, Drostanolone Propionate, Trenbolone Acetate
Manufacturer: Dragon Pharmaceutical
Package: 30 x 10 mL vial (150 mg/mL)
Price: 30 x $36.00

Primobolan 100

Injectable Steroid for Muscle Growth
Basal Constituent: Methenolone Enanthate
Made by: Dragon Pharmaceuticals
10 mL Sterile Multi-dose Vial (100 mg/mL)

Clenbuterol

Prime Chemical Name: Clenbuterol Hydrochloride
Producer: Dragon Pharma Labs
Pack: 100 pills (40 mcg/tab)

EQ 200 / Test E 200

Injectable Steroid for Muscle Growth
Mix of: Boldenone Undecylenate, Testosterone Enanthate
Manufacturer: Dragon Pharma
10 mL Sterile Multi-dose Vial (400 mg/mL)

Parabolan 100

Injectable Steroid for Muscle Growth
Main Ingredient: Trenbolone Hexahydrobenzylcarbonate
Produced by: Dragon Pharma LLC
10 mL Sterile Multi-dose Vial (100 mg/mL)